| Literature DB >> 35073954 |
Yinglong Xu1,2, Xiaobo Guo3, Hui Peng4, Hai Dai1, Zonggui Huang5, Jinmin Zhao6.
Abstract
BACKGROUND: Surgical treatment is advised for unstable distal clavicle fractures (UDCFs). Various kinds of internal fixation methods have been used, but the best fixation is still controversial.Entities:
Keywords: CMS; Complications; Network meta-analysis; Systematic review; Unstable distal clavicle fracture
Mesh:
Year: 2022 PMID: 35073954 PMCID: PMC8785604 DOI: 10.1186/s13018-021-02904-6
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Fig. 1Flowchart of the literature selection
Baseline characteristics of included studies
| References | Country | Study design | Duration | Fixation methods | No. of patients | Age (years) | Gender (M/F) | Neer type | Follow-up (months) | Outcomes | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wang et al. [ | China | Retrospective | 2014.8–2018.4 | HP/LCP | 64 (33/31) | 37.0 ± 10.0 | 38.8 ± 8.6 | 21/12 | 19/12 | II | 12 | 1, 2, 4, 5, 6, 7, 8 | |
| Li et al. [ | China | Retrospective | 2015.1–2017.5 | HP/LCP | 44 (26/18) | 51.7 ± 17.1 | 55.2 ± 16.3 | 16/10 | 11/7 | II, V | 17.2 (13–19) | 1, 4, 6, 7, 8 | |
| Chen et al. [ | USA | Retrospective | 2009–2019 | HP/LCP | 31 (12/19) | 40 ± 15 | 44 ± 13 | 10/2 | 15/4 | II, V | 31 ± 31 | 40 ± 36 | 4 |
| Ochen et al. [ | Netherlands | Retrospective | 2011.1–2016.6 | HP/LCP | 67 (19/48) | 42 ± 17 | 43 ± 12 | 13/6 | 41/7 | II, V | 31.3 ± 16.3 | 40.0 ± 18.0 | 4 |
| Singh et al. [ | USA | Retrospective | 2010.1–2012.9 | HP/LCP | 53 (16/37) | 31.7 ± 16.0 | 36.2 ± 15.9 | 10/6 | 27/10 | II, V | NR | 4 | |
| Xiong et al. [ | China | Retrospective | 2001–2010 | HP/LCP | 30 (25/5) | 46.5 ± 15.8 | 38.0 ± 14.7 | 34/24 | II | 77.4 ± 34.6 | 76.2 ± 72.4 | 4, 5, 6, 7 | |
| Erdle et al. [ | Germany | Retrospective | 2004–2016 | HP/LCP | 32 (19/13) | 44.3 ± 14.9 | 43.7 ± 13.7 | NR | IIB | 54.9 ± 19.8 | 53.3 ± 19.6 | 1, 4 | |
| Cai et al. [ | China | Prospective | 2011.3–2013.3 | HP/LCP | 40 (20/20) | 33.3 ± 7.5 | 32.9 ± 6.6 | 15/5 | 16/4 | II | NR | 2, 4, 6, 7 | |
| Zhu et al. [ | China | Retrospective | 2008.1–2011.12 | HP/LCP | 46 (26/20) | 40.3 (20–57) | 31/15 | II | NR | 1, 4, 8 | |||
| Zhang et al. [ | China | Retrospective | 2007.2–2010.11 | HP/LCP | 66 (30/36) | 41.1 ± 10.3 | 42.5 ± 10.7 | 17/13 | 20/16 | II | 27.2 ± 6.1 | 28.6 ± 6.2 | 1, 4 |
| Tan et al. [ | China | Retrospective | 2007–2009 | HP/LCP | 42 (23/19) | 41.8 ± 11.1 | 40.5 ± 9.6 | 15/8 | 13/6 | II | 22.1 ± 9.3 | 22.4 ± 10.1 | 2, 4, 6, 8 |
| Dai et al. [ | China | Retrospective | 2008.1–2009.1 | HP/LCP | 45 (25/20) | 35.6 (21–46) | 36.5 (24–51) | 17/8 | 13/7 | II | 15.6 (12–24) | 4 | |
| Wang et al. [ | China | Retrospective | 2014.10–2016.10 | HP/CC | 50 (25/25) | 44.8 ± 13.9 | 43.3 ± 14.3 | 15/10 | 19/6 | IIB | 12.7 ± 4.0 | 4, 5, 6, 7 | |
| Wu et al. [ | China | Prospective | 2015.10–2018.2 | HP/CC | 26 (14/12) | 48.9 ± 16.5 | 44.8 ± 10.3 | 8/6 | 9/3 | II | 18.9 ± 3.5 | 17.0 ± 4.2 | 1, 2, 4, 5, 6, 7 |
| Singh et al. [ | USA | Retrospective | 2010.1–2012.9 | HP/CC | 37 (16/21) | 31.7 ± 16.0 | 43.8 ± 19.6 | 10/6 | 16/4 | II, V | NR | 4 | |
| Xiang et al. [ | China | Retrospective | 2009.1–2015.10 | HP/CC | 66 (34/32) | 40.2 ± 11.4 | 41.8 ± 12.7 | 26/8 | 22/10 | IIB | 30.5 ± 7.1 | 29.1 ± 5.6 | 1, 4, 6, 8 |
| Xiong et al. [ | China | Retrospective | 2001–2014 | HP/CC | 53 (25/28) | 46.5 ± 15.8 | 41.9 ± 13.5 | 34/24 | II | 77.4 ± 34.6 | 35.6 ± 13.9 | 4, 5, 7 | |
| Hsu et al. [ | China (TW) | Retrospective | 2010–2014 | HP/CC | 72 (49/23) | 47.9 ± 19.5 | 42.4 ± 15.9 | 29/20 | 16/7 | II, V | 13.3 ± 2.5 | 14.2 ± 1.9 | 1, 2, 4, 8 |
| Xu et al. [ | China | Retrospective | 2013.4–2015.6 | HP/CC | 42 (22/20) | 33.8 ± 10.7 | 37.7 ± 9.9 | 14/8 | 11/9 | II | 7.2 (6–12) | 4, 6, 7 | |
| Flinkkilä et al. [ | Finland | Retrospective | 2007–2012 | HP/CC | 40 (19/21) | 45 ± 13 | 39 ± 14 | 13/6 | 20/1 | II | 62 ± 21 | 32 ± 16 | 1, 4 |
| Lu et al. [ | China | Retrospective | 2009.5–2010.5 | HP/CC | 40 (19/21) | 34.3 ± 1.8 | 33.2 ± 1.5 | 11/8 | 11/10 | IIB | 12–24 | 1, 4, 8 | |
| Chen et al. [ | China (TW) | Retrospective | 2004.12–2010.8 | HP/CC | 68 (28/40) | 48.3 (28–78) | 43.2 (18–75) | 16/12 | 28/12 | IIB | 37.4 (24–68) | 38.2 (24–64) | 4 |
| Wu et al. [ | China | Retrospective | 2008.1–2010.3 | HP/CC | 42 (30/12) | 37.5 ± 2.8 | 36.8 ± 1.5 | 22/8 | 9/3 | II | 12.6 (3–18) | 4, 5, 6, 7 | |
| Seo et al. [ | Korea | Retrospective | 2011.1–2019.3 | HP/LCP + CC | 82 (54/28) | 43.9 ± 15.8 | 45.6 ± 18.2 | 35/19 | 18/10 | IIB | 18.7 ± 4.2 | 15.6 ± 2.1 | 1, 4, 6, 8 |
| Hu et al. [ | China | Retrospective | 2011.4–2018.5 | HP/LCP + CC | 42 (23/19) | 41.6 ± 13.2 | 14/9 | 12/7 | II | 17.5 ± 4.7 | 1, 3, 4, 6, 7, 8 | ||
| Zeng et al. [ | China | Retrospective | 2012–2016 | HP/LCP + CC | 39 (18/21) | 43.4 ± 13.9 | 41.7 ± 14.0 | 7/11 | 11/10 | IIB | 24.6 ± 6.6 | 1, 3, 4, 6, 7, 8 | |
| Helfen et al. [ | Germany | Retrospective | 2011.11–2015.11 | HP/LCP + CC | 41 (21/20) | 39.7 ± 14.6 | 53 ± 17.5 | NR | IIB | NR | 1, 4 | ||
| Lin et al. [ | China | Retrospective | 2012.1–2015.1 | HP/LCP + CC | 65 (32/33) | 41.2 ± 9.9 | 42.6 ± 10.4 | 18/14 | 21/12 | IIB | 15.2 ± 2.1 | 14.6 ± 5.2 | 1, 4, 8 |
| Gao et al. [ | China | Retrospective | 2010.8–2013.8 | HP/LCP + CC | 42 (20/22) | 45.6 ± 12.4 | 44.2 ± 11.6 | 11/9 | 14/8 | IIB | 16.8 (10–24) | 1, 3, 4, 8 | |
| Bhatia et al. [ | Australia | Retrospective | 2005–2008 | HP/LCP + CC | 15 (10/5) | 34.5 (20–57) | 13/2 | IIB | 26.1 (12–40) | 4 | |||
| Dey Hazra et al. [ | Germany | Retrospective | 2014–2017 | LCP/LCP + CC | 31 (14/17) | 43 ± 15 | 43 ± 17 | 9/5 | 9/8 | IIB | 29 ± 12.4 | 18 ± 7.1 | 1, 3, 4, 6 |
| Salazar et al. [ | USA | Retrospective | 2009–2019 | LCP/LCP + CC | 23 (16/7) | 42 ± 13 | 45 ± 13 | 14/2 | 5/2 | II, V | 28 ± 34 | 47 ± 39 | 4 |
| Zhang et al. [ | China | Retrospective | 2013.1–2015.1 | LCP/LCP + CC | 40 (20/20) | 37.3 ± 10.6 | 40.6 ± 12.6 | 16/4 | 15/5 | IIB | 30.1 ± 6.7 | 1, 3, 4, 5, 6, 7, 8 | |
| Xu et al. [ | China | Retrospective | 2010.2–2017.1 | LCP/LCP + CC | 34 (16/18) | 50.7 ± 17.7 | 45.5 ± 14.4 | 9/7 | 12/6 | IIB | 16.0 | 17.5 | 1, 4, 8 |
| Tang et al. [ | China | Retrospective | 2013.2–2017.1 | LCP/LCP + CC | 40 (22/18) | 45.4 (26–65) | 43.3 (24–61) | 10/12 | 11/7 | IIB | 16.3 (12–27) | 1, 4, 6 | |
| Fan et al. [ | China | Retrospective | 2013.1–2015.1 | LCP/LCP + CC | 28 (10/18) | 40.2 ± 12.6 | 36.9 ± 11.0 | 7/3 | 14/4 | II | 21.8 ± 7.7 | 18.4 ± 3.6 | 1, 2, 3, 4, 5, 6, 7, 8 |
| Mechchat et al. [ | Morocco | Prospective | 2009–2013 | HP/KWTB | 26 (14/12) | 34.2 ± 13.7 | 29 ± 13.7 | 8/6 | 5/7 | II | 12 | 1, 4, 8 | |
| Wu et al. [ | China (TW) | Retrospective | 2007.1–2010.6 | HP/KWTB | 116 (92/24) | 49.3 ± 15.5 | 50.7 ± 17.6 | 55/37 | 17/7 | II | 22.8 ± 2.2 | 25.7 ± 2.8 | 1, 4 |
| Hsu et al. [ | China (TW) | RCT | 2005.2–2008.11 | HP/KWTB | 65 (35/30) | 43.2 ± 12.8 | 41.3 ± 13.6 | 23/12 | 21/9 | II | 6 | 4 | |
| Lee et al. [ | China (TW) | Retrospective | 2000–2007 | HP/KWTB | 52 (32/20) | 43.4 | 35.9 | 18/14 | 9/11 | II | 24.3 | 29.8 | 1, 4 |
| Flinkkilä et al. [ | Finland | Retrospective | 1988–1999 | HP/KWTB | 39 (17/22) | 43 (18–71) | 35 (17–68) | 16/1 | 16/6 | II | 24 | 74.4 | 4 |
| Tsuei et al. [ | China (TW) | Retrospective | 2002–2008 | KW/KWTB | 29 (14/15) | 39.2 ± 15.0 | 39.3 ± 14.1 | 9/5 | 11/4 | II | 8.62 (6–20) | 2, 4, 6, 8 | |
| Seyhan et al. [ | Turkey | Retrospective | 2000–2011 | KWTB + CC/LCP + CC | 24 (10/14) | 36.1 (20–55) | 6/4 | 10/4 | IIB | NR | 1, 4 |
RCT randomized controlled trail, HP hook plate, LCP locking compression plate, CC coracoclavicular reconstruction, LCP + CC combination of locking compression plate and coracoclavicular reconstruction, KWTB Kirshner wire and tension band, KWTB + CC combination of Kirshner wire and tension band and coracoclavicular reconstruction, KW Kirshner wire, NR not reported
Outcomes: 1, Constant Murley Score (CMS); 2, University of California at Los Angeles (UCLA) score; 3, coracoclavicular distance (CCD); 4, complications; 5, incision; 6, operative time; 7, blood loss; 8, union time
Fig. 2Forest plots of the meta-analysis of different internal fixation methods for UDCFs. A CMS; B Total complications. 1, HP; 2, LCP; 3, CC; 4, LCP + CC; 5, KWTB; 6, KWTB + CC; 7, KW
Fig. 3Network meta-analysis maps of CMS and total complications. A CMS; B Total complications. Each node represents an intervention, and the size of the node is proportional to the number of patients assigned to the intervention. The lines indicate direct comparisons between nodes, and the size of the line is proportional to the number of trials comparing each pair of nodes
League table of different internal fixation comparisons of CMS, UCLAs, and CCD for UDCF
| 0.77 (0.27, 1.28)a | NR | NR | 1.09 (0.39, 1.79)a | NR | |
| 0.60 (0.19, 1.02)* | NR | NR | 0.70 (0.23, 1.17)a | NR | |
| 0.63 (− 0.01, 1.26) | 0.02 (− 0.62, 0.67) | NR | 0.55 (0.29, 0.82) | NR | |
| 1.17 (− 0.12, 2.46) | 0.56 (− 0.79, 1.92) | 0.54 (− 0.90, 1.98) | NR | NR | |
| 1.16 (0.77, 1.55)* | 0.56 (0.15, 0.96)* | 0.53 (0.03, 1.03)* | − 0.01 (− 1.36, 1.34) | 0.76 (0.43, 1.09) | |
| 1.88 (1.12, 2.63)* | 1.27 (0.51, 2.03)* | 1.25 (0.43, 2.07)* | 0.71 (− 0.79, 2.20) | 0.72 (0.07, 1.36)* | |
| NR | NR | NR | |||
| 0.53 (− 1.38, 2.44) | NR | 1.24 (0.78, 1.69) | |||
| 0.63 (− 0.81, 2.07) | 0.10 (− 1.16, 1.35) | 1.05 (0.16, 1.94)a | |||
| 1.65 (0.01, 3.29)* | 1.12 (0.15, 2.09)* | 1.02 (0.23, 1.81)* | |||
| NR | − 0.78 (− 1.82, 0.25)b | ||||
| − 0.76 (− 1.76, 0.23) | − 0.30 (− 1.25, 0.64)b | ||||
| − 1.06 (− 2.48, 0.36) | − 0.29 (− 1.30, 0.72) | ||||
Fixation methods are ordered by the SUCRA value, and the top left is the best, whereas the bottom right is the worst. Estimates on the upper right are direct comparisons (i.e., head- to-head studies); the lower-left estimates are from the network meta-analysis
MD (95% CI) mean difference and 95%confidence interval, OR (95% CI) odd ratio and 95%confidence interval, HP hook plate, LCP locking compression plate, CC coracoclavicular reconstruction, LCP + CC, combination of locking compression plate and coracoclavicular reconstruction, KWTB Kirshner wire and tension band, KWTB + CC combination of Kirshner wire and tension band and coracoclavicular reconstruction, KW Kirshner wire, NR not reported, NFT no further treatment
aSignificant heterogeneity was tested between the direct comparisons, and sensitivity analysis confirmed the robustness of the results
bSignificant heterogeneity was tested between the direct comparisons
*p value < 0.05 statistically significant different
Fig. 4Rankogram of different internal fixation methods for CMS and total complications. A CMS; B Total complications
Fig. 5Network meta-analysis funnel plots for the assessment of publication bias of the included studies. A CMS; B Total complications. A HP, B LCP, C CC, D LCP + CC, E KWTB, F KWTB + CC, G KW
League table of different internal fixation comparisons of complications for UDCF
| 0.55 (0.23, 1.29) | NR | NR | 0.19 (0.05, 0.66) | NR | ||
| 0.65 (0.27, 1.53) | NR | NR | 0.25 (0.12, 0.52)b | NR | ||
| 0.38 (0.12, 1.20) | 0.59 (0.21, 1.69) | NR | 0.53 (0.22, 1.28)b | NR | ||
| 0.27 (0.02, 2.98) | 0.42 (0.03, 5.37) | 0.72 (0.05, 10.20) | NR | NR | ||
| 0.22 (0.09, 0.51)* | 0.34 (0.16, 0.71)* | 0.57 (0.26, 1.25) | 0.80 (0.06, 10.09) | 0.22 (0.06, 0.84)a | ||
| 0.05 (0.01, 0.20)* | 0.08 (0.02, 0.29)* | 0.14 (0.04, 0.50)* | 0.20 (0.01, 3.03) | 0.25 (0.09, 0.67)* | ||
| 0.01 (0.00, 0.11)* | 0.01 (0.00, 0.17)* | 0.01 (0.00, 0.29)* | 0.02 (0.00, 0.93)* | 0.02 (0.00, 0.46)* | 0.10 (0.01, 1.55) | |
| 2.92 (0.89, 9.59)b | NR | NR | 0.40 (0.22, 0.75) | NR | ||
| 0.78 (0.34, 1.80) | NR | NR | 0.18 (0.06, 0.50) | NR | ||
| 0.62 (0.18, 2.14) | 0.79 (0.24, 2.59) | NR | 0.47 (0.13, 1.75) | NR | ||
| 0.72 (0.01, 45.37) | 0.93 (0.01, 63.35) | 1.17 (0.02, 88.04) | NR | NR | ||
| 0.31 (0.14, 0.70)* | 0.40 (0.19, 0.85)* | 0.50 (0.20, 1.28) | 0.43 (0.01, 29.00) | NR | ||
| 0.12 (0.03, 0.43)* | 0.16 (0.05, 0.52)* | 0.20 (0.05, 0.73)* | 0.17 (0.00, 12.76) | 0.40 (0.16, 0.98)* | ||
| 0.01 (0.00, 0.20)* | 0.01 (0.00, 0.24)* | 0.02 (0.00, 0.32)* | 0.02 (0.00, 2.40) | 0.04 (0.00, 0.55)* | 0.10 (0.01, 1.19) | |
| NR | 0.35 (0.08, 1.57) | 0.03 (0.00, 0.33) | NR | NR | ||
| 0.68 (0.19, 2.37) | NR | 0.26 (0.10, 0.67) | NR | NR | ||
| 0.46 (0.18, 1.18) | 0.68 (0.23, 1.98) | 0.82 (0.21, 3.26) | NR | NR | ||
| 0.34 (0.12, 0.92)* | 0.50 (0.22, 1.13) | 0.73 (0.33, 1.63) | 0.36 (0.09, 1.45) | NR | ||
| 0.14 (0.03, 0.73)* | 0.21 (0.04, 0.96)* | 0.30 (0.06, 1.41) | 0.41 (0.11, 1.53) | NR | ||
| 0.03 (0.00, 0.73) | 0.05 (0.00, 1.39) | 0.07 (0.00, 1.83) | 0.10 (0.00, 2.55) | 0.25 (0.01, 8.00) | 2.60 (0.04, 166.59) | |
| 0.01 (0.00, 0.22)* | 0.02 (0.00, 0.31)* | 0.03 (0.00, 0.45)* | 0.04 (0.00, 0.55)* | 0.10 (0.01, 0.94)* | ||
| NR | NR | 0.42 (0.05, 3.70) | NR | NR | ||
| 0.74 (0.26, 2.13) | NR | 0.71 (0.24, 2.16) | NR | NR | ||
| 0.73 (0.19, 2.75) | 0.99 (0.31, 3.12) | 0.82 (0.27, 2.55) | NR | NR | ||
| 0.67 (0.24, 1.85) | 0.90 (0.40, 2.05) | 0.91 (0.38, 2.19) | 0.53 (0.10, 2.92) | NR | ||
| 0.49 (0.04, 6.28) | 0.66 (0.06, 7.88) | 0.67 (0.06, 8.14) | 0.74 (0.07, 7.61) | NR | ||
| 0.07 (0.00, 1.63) | 0.10 (0.00, 2.62) | 0.10 (0.00, 2.93) | 0.11 (0.00, 2.88) | 0.15 (0.00, 8.25) | 0.19 (0.01, 6.31) | |
| 0.39 (0.07, 2.04) | 0.53 (0.11, 2.46) | 0.53 (0.11, 2.57) | 0.59 (0.16, 2.15) | 0.79 (0.07, 9.22) | ||
aSignificant heterogeneity was tested between the direct comparisons, and sensitivity analysis confirmed the robustness of the results
bSignificant heterogeneity was tested between the direct comparisons
*p value < 0.05 statistically significant different
League table of different internal fixation comparisons of surgical outcomes for UDCF
| NR | NR | − 3.66 (− 4.54, − 2.77)a | |||
| − 3.13 (− 4.60, − 1.66)* | − 0.32 (− 0.80, 0.17) | − 0.76 (− 2.6, 1.08)b | |||
| − 3.45 (− 5.39, − 1.51)* | − 0.32 (− 1.58, 0.94) | NR | |||
| − 3.70 (− 4.66, − 2.75)* | − 0.57 (− 1.83, 0.69) | − 0.25 (− 2.04, 1.53) | |||
| − 0.01 (− 0.28, 0.27) | − 0.48 (− 0.82, − 0.14) | NR | |||
| 0.50 (− 0.50, 1.51) | − 0.26 (− 0.58, 0.06) | − 0.27 (− 0.51, − 0.02) | |||
| − 0.30 (− 0.73, 0.13) | 0.43 (− 0.18, 1.05) | NR | |||
| − 0.65 (− 1.28, − 0.03)* | 0.04 (− 0.24, 0.33) | − 0.35 (− 0.99, 0.28) | |||
| NR | − 1.8 (− 3.70, 0.12)b | NR | |||
| − 1.33 (− 3.12, 0.47) | − 0.07 (− 0.38, 0.24) | − 0.39 (− 0.88, 0.10) | |||
| − 1.60 (− 2.96, − 0.24)* | − 0.27 (− 1.62, 1.07) | − 0.36 (− 0.80, 0.08) | |||
| − 1.85 (− 3.96, 0.26) | − 0.52 (− 2.20, 1.15) | − 0.25 (− 1.92, 1.42) | |||
| NR | − 0.40 (− 0.80, 0.00) | NR | − 0.61 (− 1.16, − 0.05)* | NR | |
| − 0.08 (− 1.42, 1.26) | NR | NR | NR | NR | |
| − 0.34 (− 0.85, 0.18) | − 0.25 (− 1.60, 1.10) | NR | − 0.37 (− 1.03, 0.30)b | NR | |
| − 0.30 (− 2.11, 1.52) | − 0.21 (− 1.44, 1.01) | 0.04 (− 1.78, 1.86) | NR | NR | |
| − 0.64 (− 1.08, − 0.19)* | − 0.55 (− 1.82, 0.71) | − 0.30 (− 0.78, 0.18) | − 0.34 (− 2.10, 1.42) | − 0.18 (− 0.82, 0.47)b | |
| − 0.81 (− 1.60, − 0.02)* | − 0.73 (− 2.15, 0.69) | − 0.47 (− 1.28, 0.33) | − 0.51 (− 2.39, 1.36) | − 0.17 (− 0.82, 0.47) | |
aSignificant heterogeneity was tested between the direct comparisons, and sensitivity analysis confirmed the robustness of the results
bSignificant heterogeneity was tested between the direct comparisons
*p value < 0.05 statistically significant different
Fig. 6Cluster-rank plot of CMS and total complications for UDCFs